Mr. Rob Carducci reports

GLOW COMMISSIONS NEW AUTOMATED BOTTLING LINE SUPPORTING SCALE-UP AND LAUNCHES CBG-BASED PRODUCT IN ONTARIO

Glow Lifetech Corp. has provided a commercial update highlighting continued progress in scaling its operations and expanding its innovative product portfolio. Glow has successfully commissioned a new automated bottling line to support its growth trajectory and secured a new Ontario product listing for MOD CBG:THC Drops 300, introducing the emerging minor cannabinoid CBG.

Glow commissions new automated bottling line

Glow has completed the commissioning of its new automated bottling system at its production facility, significantly increasing its production throughput and operational efficiency. This strategic infrastructure upgrade supports the company's scale-up efforts as it deepens its presence in Ontario and enters new markets.

"This investment in automation marks a key milestone in scaling our operations to meet growing demand for our flagship MOD brand that we expect to continue to build into the second half of 2025," said Rob Carducci, chief executive officer of Glow Lifetech. "We're now equipped with the infrastructure to fulfill materially higher orders volumes while enhancing unit economics and supply chain agility as we continue to scale."

New Ontario listing: MOD CBG:THC 300

Building on the successful launch of its CBN-based SKUs (stock-keeping units) in Q2, Glow has secured a new product listing in Ontario for MOD CBG:THC Drops 300, a fast-acting, flavourless water-soluble formulation that introduces the emerging minor cannabinoid CBG. Expected to launch in late summer and is the latest addition to MOD's growing minor cannabinoid lineup, further reinforcing Glow's leadership in differentiated formulations tailored to emerging consumer trends.

"CBG is an emerging minor cannabinoid in the market today with unique properties, and we're proud to be at the forefront of bringing it to consumers in a fast-acting, water-soluble format with MOD CBG:THC drops," said Rob Carducci, chief executive officer of Glow Lifetech. "It's another example of how we continue to lead through meaningful, differentiated innovation that reflect where the cannabis category is headed."

Momentum builds into second half of 2025

In addition to scaling infrastructure and launching new listings, the company continues to see strong and growing demand in its core Ontario market, where it believes significant headroom for growth remains. With interest building from major retail accounts, these relationships are not only driving deeper retail penetration within Ontario, but also helping to advance select new provincial opportunities. As a result, Glow enters the second half of 2025 with strong momentum and a strategic foundation for long-term growth.

About Glow Lifetech Corp.

Glow Lifetech is a Canadian-based biotechnology company focused on producing nutraceutical and cannabinoid-based products with dramatically enhanced bioavailability, absorption and effectiveness. Glow has a groundbreaking, plant-based MyCell Technology delivery system, which transforms poorly absorbed natural compounds into enhanced water-compatible concentrates that unlock the full healing potential of the valuable compounds.

We seek Safe Harbor.